Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neuromuscul Disord. 2014 Nov;24(11):960-72. doi: 10.1016/j.nmd.2014.06.001. Epub 2014 Jun 10.

Advances in the understanding of skeletal muscle weakness in murine models of diseases affecting nerve-evoked muscle activity, motor neurons, synapses and myofibers.

Author information

  • 1Université Pierre et Marie Curie - Paris 6, Sorbonne Universités, UMR S794, INSERM U974, CNRS UMR 7215, Institut de Myologie, Paris F-75013, France; Université Paris Descartes, Sorbonne Paris Cité, Paris F-75006, France. Electronic address: arnaud.ferry@upmc.fr.
  • 2Université Paris Diderot, Sorbonne Paris Cité, CNRS EAC 4413, Unit of Functional and Adaptive Biology, Laboratory of Stress and Pathologies of the Cytoskeleton, Paris F-75013, France.
  • 3Université Pierre et Marie Curie - Paris 6, Sorbonne Universités, UMR S794, INSERM U974, CNRS UMR 7215, Institut de Myologie, Paris F-75013, France.
  • 4Université Paris Descartes, Sorbonne Paris Cité, Laboratoire de Biologie de la Nutrition EA 2498, Paris, France.
  • 5Université Paris Descartes, Sorbonne Paris Cité, CESeM, UMR 8194 CNRS, Paris F-75006, France.
  • 6Universités Montpellier 1 et 2, INRA, UMR 866, Montpellier, France.
  • 7Universitätsklinikum Erlangen, Neuropathologisches Institut, Erlangen, Germany.
  • 8Université Pierre et Marie Curie - Paris 6, INSERM U975, Centre de recherche de l'Institut Cerveau Moelle, CNRS UMR 7225, Paris, France.

Abstract

Disease processes and trauma affecting nerve-evoked muscle activity, motor neurons, synapses and myofibers cause different levels of muscle weakness, i.e., reduced maximal force production in response to voluntary activation or nerve stimulation. However, the mechanisms of muscle weakness are not well known. Using murine models of amyotrophic lateral sclerosis (SOD1(G93A) transgenic mice), congenital myasthenic syndrome (AChE knockout mice and Musk(V789M/-) mutant mice), Schwartz-Jampel syndrome (Hspg2(C1532YNEO/C1532YNEO) mutant mice) and traumatic nerve injury (Neurotomized wild-type mice), we show that the reduced maximal activation capacity (the ability of the nerve to maximally activate the muscle) explains 52%, 58% and 100% of severe weakness in respectively SOD1(G93A), Neurotomized and Musk mice, whereas muscle atrophy only explains 37%, 27% and 0%. We also demonstrate that the impaired maximal activation capacity observed in SOD1, Neurotomized, and Musk mice is not highly related to Hdac4 gene upregulation. Moreover, in SOD1 and Neurotomized mice our results suggest LC3, Fn14, Bcl3 and Gadd45a as candidate genes involved in the maintenance of the severe atrophic state. In conclusion, our study indicates that muscle weakness can result from the triggering of different signaling pathways. This knowledge may be helpful in designing therapeutic strategies and finding new drug targets for amyotrophic lateral sclerosis, congenital myasthenic syndrome, Schwartz-Jampel syndrome and nerve injury.

Copyright © 2014 Elsevier B.V. All rights reserved.

KEYWORDS:

Murine models; Neuromuscular diseases; Skeletal muscle weakness

PMID:
25042397
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk